What Oak Longevity sells and charges
- Brand medications
- Wegovy pill (oral semaglutide), Branded GLP-1 injector pens (brand not named on the page)
- Compounded GLP-1
- Yes
- Membership
- Not printed; the Terms say a membership fee covering the provider consult is charged at checkout
- Medication price from
- GLP-1 treatments from $89/mo (homepage line; no per-medication or per-plan price is printed)
- Insurance
- Cash pay only
- How you are prescribed
- Questionnaire, with a video visit when required
- States
- 45 states per the Terms of Use; the homepage says licensed in all 50
Medications, insurance, prescribing and states: from the Oak Longevity pages listed in Sources, read on .
Prices read from the program's own price page on . Prices change; the page you land on is the one that counts.
The public record
FDA warning letters, FTC actions and state attorney general actions: none found on . The searches are listed in the sources.
What to know before you sign up
Oak Longevity prices its program as a single "from $89/mo" line on the homepage and nowhere else. The GLP-1 page lists four routes, compounded semaglutide, compounded tirzepatide, unnamed branded injector pens and the oral Wegovy tablet, with no price on any of them, and the intake asks how much weight you want to lose before it shows a plan. The Terms say checkout adds a membership fee for the provider consult without printing the amount; the consult itself is "contracted at $40" for a video visit and $20 for an asynchronous review.
The company name depends on which paragraph you read. The Terms open with "Leaf Longevity Holdings Corp. DBA Oak Longevity", define the Company as "Oak Longevity Holdings Corp." and introduce "Oak Longevity Corp" a few lines later; the footer uses Oak Longevity Holdings Corp., and the telehealth consent covers RetaClinic, Flow Longevity and Mito Health Holdings Corp. as well.
One thing has changed since our August check. The footer on every page now says "Compounded medications are not FDA approved", which was absent then, and the homepage FAQ repeats it. Still there: the Terms say service covers 45 states while the homepage says licensed in all 50, and once a provider approves an order it "can no longer be cancelled and is non-refundable", so the cancel-any-time promise covers future renewals, not the order in progress.
Frequently asked questions
Who owns Oak Longevity?
The Terms of Use, effective December 30, 2025, open with "Leaf Longevity Holdings Corp. DBA Oak Longevity" and elsewhere define the company as Oak Longevity Holdings Corp., which also operates RetaClinic and Flow Longevity; governing law is Delaware. On September 23, 2026 the FDA warning-letter list, the FTC case library and a web search for attorney general or medical board actions returned nothing under either name.
How much does Oak Longevity cost?
The homepage says "Prescription weight loss from $89/mo. No insurance needed." That is the only price on the site as of September 23, 2026; the GLP-1 page prices none of its four treatments, and the Terms say a membership fee for the provider consult is added at checkout. Oak does not work with insurance, and the Terms say Medicare and Medicaid do not cover its products.
Are Oak Longevity's GLP-1 medications FDA approved?
Two of the four are not. Oak sells compounded semaglutide and compounded tirzepatide injections, and its footer states "Compounded medications are not FDA approved." It also lists the oral Wegovy tablet, an FDA-approved product, and branded injector pens it does not name on the page. The compounding pharmacy is not named.
Was this helpful?
Your feedback shapes what we cover next.
Thanks for letting us know.
If you found this useful, sign up for our newsletter to get more like this.
Thanks. What was missing?
Optional. We read every response.
Thanks.
We use this to prioritize the next round of edits.